Galmed Pharmaceuticals
GLMD
GLMD
25 hedge funds and large institutions have $14.6M invested in Galmed Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Holders
25
Holding in Top 10
1
Calls
$81K
Puts
$194K
Top Buyers
| 1 | +$179K | |
| 2 | +$120K | |
| 3 | +$36K | |
| 4 |
BAM
Brave Asset Management
Summit,
New Jersey
|
+$35K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$30.5K |
Top Sellers
| 1 | -$925K | |
| 2 | -$818K | |
| 3 | -$634K | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$292K |
| 5 |
Renaissance Technologies
New York
|
-$208K |